Mika Taylor

Researcher

University of Arkansas for Medical Sciences

unknown

2 h-index 4 pubs 11 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Mika Taylor's research focuses on developing novel cancer immunotherapies. This work includes investigating the repurposing of the live attenuated trivalent MMR vaccine as a cost-effective treatment for cancer. Additionally, Taylor studies the enhancement of immune responses and survival rates in hepatocellular carcinoma through the use of the oncolytic Jurona virus in combination with immune checkpoint blockade. Recent publications also detail a comprehensive proteogenomic analysis of the in vivo safety and immunoactivity of the oncolytic Jurona virus in hepatocellular carcinoma models. Taylor has a publication record of four papers with 11 citations and an h-index of 2. Key collaborators include Steven R. Post, Martin J. Cannon, Camila Simões, and Bolni Marius Nagalo, all from the University of Arkansas for Medical Sciences, with whom Taylor has co-authored four publications.

Metrics

  • h-index: 2
  • Publications: 4
  • Citations: 11

Selected Publications

  • Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024) DOI
  • Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics